Join our CEO for a live Q&A: Tomorrow at 1 p.m. our CEO will be taking your questions on our response to COVID-19 in real time. To participate in the audio conference, dial toll-free at 1-800-753-0786 and use the participant passcode 238335#. Once you have joined the call, we encourage you to ask a question by pressing *1. Participants wishing to ask a question will have their line unmuted by the operator when it is their turn. Where possible, we ask employees to join us from a mobile device, as our lines are limited. More details are available on the employee portal and your Outlook invite sent by the Office of the CEO. We look forward to this opportunity to connect live with Graham and to hear your questions.
Convalescent plasma donor registry now available: We’re proud to be part of a national clinical trial to test the safety and effectiveness of COVID-19 convalescent plasma as a possible treatment option for patients with the virus. Last Friday, we launched an online registry for anyone interested in becoming a potential convalescent plasma donor. Previously, employees were asked to forward inquiries about the clinical trial to our Blood4Research facility until an online registry could be created. Now that the registry is available to the public, we ask that you direct these inquiries to blood.ca/convalescentplasma for more information and to join the registry.
Toyota Canada boosts support for Canadian Blood Services and Héma Québec: Toyota Canada along with their Lexus brand, have donated more than $1 million worth of advertising time to communicate the ongoing need for blood donations and to inform Canadians about the enhanced measures taken to protect the health and safety of our donors. Television and social media ads are going live this week, so keep an eye out and share them with your friends and family using the hashtag #CanadasLifeline and tagging @toyotacanada and @lexuscanada
The need goes on — immune system depends on donated plasma: Lisa’s story serves to remind us that what we do matters. After battling constant infections in her 20’s, she was diagnosed with common variable immune deficiency (CVID) – which fortunately can be treated with immune globulin. Lisa can administer the treatment herself at home and describes it as essential to her quality of life. “If I did not have access, I would not be able to be the mom I want to be. I know I would be chronically ill.” Read more about Lisa’s story on blood.ca.
About the daily digest
This daily digest will highlight the latest policy and employee support measures, resources to help you manage our new reality and original content like articles and videos to remind us that what we do matters. Things are moving quickly, so you can expect to hear from us daily. No access to email? No problem — all this information and more can be found on blood.ca/employees from any device, no login required.
Click here to read past editions of the daily digest.
Have questions? Check out blood.ca/employees or email us at email@example.com